Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction.MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, announced a $63.5 million Series C…
MBX Biosciences’ $63.5 Million Series C Financing Round
![](https://globallegalchronicle.com/wp-content/uploads/2024/08/mbx-biosciences-63-5-million-series-c-financing-round_66b79a3fac733.jpeg)